These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 15336568)

  • 1. Anthrax Pathogenesis.
    Moayeri M; Leppla SH; Vrentas C; Pomerantsev AP; Liu S
    Annu Rev Microbiol; 2015; 69():185-208. PubMed ID: 26195305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene synthesis demystified.
    Czar MJ; Anderson JC; Bader JS; Peccoud J
    Trends Biotechnol; 2009 Feb; 27(2):63-72. PubMed ID: 19111926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing Stable
    Ryabchevskaya EM; Granovskiy DL; Evtushenko EA; Ivanov PA; Kondakova OA; Nikitin NA; Karpova OV
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmolytes in vaccine production, flocculation and storage: a critical review.
    Hasan T; Kumari K; Devi SC; Handa J; Rehman T; Ansari NA; Singh LR
    Hum Vaccin Immunother; 2019; 15(2):514-525. PubMed ID: 30273503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural hot spots for the solubility of globular proteins.
    Ganesan A; Siekierska A; Beerten J; Brams M; Van Durme J; De Baets G; Van der Kant R; Gallardo R; Ramakers M; Langenberg T; Wilkinson H; De Smet F; Ulens C; Rousseau F; Schymkowitz J
    Nat Commun; 2016 Feb; 7():10816. PubMed ID: 26905391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
    Petersen LK; Phanse Y; Ramer-Tait AE; Wannemuehler MJ; Narasimhan B
    Mol Pharm; 2012 Apr; 9(4):874-82. PubMed ID: 22380593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of immunogenicity of anthrax vaccines subjected to thermal stress, as measured by a toxin neutralization assay.
    Castelán-Vega J; Corvette L; Sirota L; Arciniega J
    Clin Vaccine Immunol; 2011 Feb; 18(2):349-51. PubMed ID: 21147935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the development of next-generation anthrax vaccines.
    Friedlander AM; Little SF
    Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal inactivation of protective antigen of Bacillus anthracis and its prevention by polyol osmolytes.
    Singh S; Singh A; Aziz MA; Waheed SM; Bhat R; Bhatnagar R
    Biochem Biophys Res Commun; 2004 Sep; 322(3):1029-37. PubMed ID: 15336568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The osmoprotectants glycine and its methyl derivatives prevent the thermal inactivation of protective antigen of Bacillus anthracis.
    Singh S; Aziz MA; Khandelwal P; Bhat R; Bhatnagar R
    Biochem Biophys Res Commun; 2004 Apr; 316(2):559-64. PubMed ID: 15020254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
    Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR; Cui Z
    J Pharm Pharmacol; 2006 Apr; 58(4):439-47. PubMed ID: 16597361
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.